Founder & President Solaris Pharma Corporation BRIDGEWATER, New Jersey
Development of topical products provide unique challenges in the formulation development, scale up & manufacturing and bioequivalence studies. Some challenges include, but not limited to variability in performance of the reference product, establishing bioequivalence using in vitro techniques especially, skin permeation studies and scaling up to commercial batch sizes. Some of these challenges can be overcome using artificial intelligence & machine learning. This talk will cover some of these aspects of topical product development.
Learning Objectives:
Upon completion, participant will be able to understand some of the unique challenges encountered in topical product development.
Upon completion paticipants will be able to learn about some novel strategies that one can adopt to oversome some of the challenges in developing topical products
Upon completion, participants will learn how artificial intelligence (AI) can aid in topical product development and scale up.